custom image

Antibodies and Vaccines as Drugs for COVID-19

January 13-14, 2021 | 9:00AM EST | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

COVID-19 has brought unprecedented society level attention on a truly global scale into antibody and vaccine science and technology. Billions of people are now aware of antibodies, therapeutic, protective and diagnostic and vaccine design, manufacturing and clinical trial design. On a medical level, COVID-19 has impacted every single country on the planet with currently 33 million confirmed infections and 1 million deaths. These numbers will continue to increase until natural immunity, improved therapeutic interventions, vaccines or a combination of all three succeed. This COVID event is simply the biggest medical and economic threat in modern history and antibody and vaccine science is at its core. This conference will bring together in an accessible on-line format key influencers and scientific advances from around the world and unite the scientific community in the first steps of defeating COVID-19.

Keystone Symposia is unable to host its ‘Antibodies as Drugs’ meeting as planned in January 2021 but will be replaced in part in a smaller COVID focused on-line meeting called 'Antibodies and Vaccines as Drugs for COVID-19'. The meeting will have two 2½ hour on-line sessions, timed to fit in with most major time zones, each comprised of nine x 15 minutes invited oral presentations. One session will have a dedicated therapeutic antibody focus the other will have a vaccine focus. Join the meeting to find out the very latest about COVID-19 therapeutic developments.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission December 29, 2020
ePoster / SciTalk Presentation: December 29, 2020
Financial Aid Application: December 29, 2020


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!

Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.

Program Details

Speaking at this eSymposia

Donita C. Brady

University of Pennsylvania, USA

Lewis C. Cantley

Weill Cornell Medicine, USA

Navdeep S. Chandel

Northwestern University, USA

Heather Christofk

University of California, Los Angeles, USA

Karin E. de Visser

Netherlands Cancer Institute, Netherlands

Ralph J. DeBerardinis

University of Texas Southwestern Medical Center, USA

Mikala Egeblad

Cold Spring Harbor Laboratory, USA

Sarah-Maria Fendt

VIB Leuven, Belgium

Johanna A. Joyce

University of Lausanne, Switzerland

Alec Kimmelman

New York University Langone Medical Center, USA

Program details will be available soon.

Subscribe to receive updates to the program for this meeting.

Email address:    


Additional Support



Funding for this conference was made possible (in part) by Grant No. 1R13CA254450-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image

Donate to Keystone Symposia

custom image